Login / Signup

RNF41 regulates the damage recognition receptor Clec9A and antigen cross-presentation in mouse dendritic cells.

Kirsteen M TullettPeck Szee TanHae-Young ParkRalf B SchittenhelmNicole MichaelRong LiAntonia N PolicheniEmily GruberCheng HuangAlex J FulcherJillian C DannePeter E CzabotarLinda M WakimJustine D MinternGeorg RammKristen J RadfordIrina CaminschiMeredith O'KeeffeJose A VilladangosMark D WrightMarnie E BlewittWilliam R HeathKen ShortmanAnthony W PurcellNicos A NicolaJian-Guo ZhangMireille H Lahoud
Published in: eLife (2020)
The dendritic cell receptor Clec9A facilitates processing of dead cell-derived antigens for cross-presentation and the induction of effective CD8+ T cell immune responses. Here, we show that this process is regulated by E3 ubiquitin ligase RNF41 and define a new ubiquitin-mediated mechanism for regulation of Clec9A, reflecting the unique properties of Clec9A as a receptor specialized for delivery of antigens for cross-presentation. We reveal RNF41 is a negative regulator of Clec9A and the cross-presentation of dead cell-derived antigens by mouse dendritic cells. Intriguingly, RNF41 regulates the downstream fate of Clec9A by directly binding and ubiquitinating the extracellular domains of Clec9A. At steady-state, RNF41 ubiquitination of Clec9A facilitates interactions with ER-associated proteins and degradation machinery to control Clec9A levels. However, Clec9A interactions are altered following dead cell uptake to favor antigen presentation. These findings provide important insights into antigen cross-presentation and have implications for development of approaches to modulate immune responses.
Keyphrases
  • dendritic cells
  • immune response
  • regulatory t cells
  • case report
  • dna damage response
  • single cell
  • palliative care
  • stem cells
  • small molecule
  • transcription factor
  • breast cancer cells